Hot Selling Nice Quality 99% Analgesic Drug Rotundine

I. Overview

1. Chemical Properties and Sources
   • Chemical Structure: Rotundine (L-Tetrahydropalmatine, L-THP) is an isoquinoline alkaloid with the molecular formula C₂₁H₂₅NO₄ (molecular weight: 355.43). It appears as a white or faint yellow crystalline powder, odorless and tasteless, with photosensitivity and thermolability (yellowing upon exposure). It is soluble in chloroform, sparingly soluble in ethanol or ether, insoluble in water, and readily soluble in dilute sulfuric acid.
   • Natural Sources: Extracted primarily from the dried tubers of Corydalis yanhusuo (Papaveraceae family), with the levorotatory isomer (L-THP, Rotundine) being the pharmacologically active form. The dextrorotatory isomer lacks significant analgesic effects.
   • 
     
2. Pharmacological Actions
   • Analgesic Effects: Rotundine blocks dopamine receptors (e.g., D₂ receptors in the striatum and nucleus accumbens) in the CNS, enhancing the descending pain-modulatory system via the periaqueductal gray (PAG)-rostral ventromedial medulla (RVM)-spinal dorsal horn pathway. This inhibits peripheral pain signal transmission at the spinal level, effective against chronic persistent and visceral dull pain but less potent for acute sharp pain.
   • Sedative-Hypnotic Effects: Produces sedation, hypnosis, and tranquilization by prolonging sleep duration and improving sleep quality, particularly for pain-induced insomnia, with no residual effects upon awakening.
   • Additional Actions: Exhibits antispasmodic effects (alleviating gastrointestinal spasms), antiarrhythmic/hypotensive activity, and mood-regulating properties (reducing depression and anxiety).
   • 
     
3. Safety and Toxicity
   • Safety Profile: Low toxicity and non-addictive; classified as a non-narcotic analgesic.
   • Adverse Reactions: Common side effects include drowsiness, fatigue, nausea, vomiting, rash, palpitations, chest tightness, dyspnea, and rare extrapyramidal symptoms (e.g., tremors, hyperkinesia, dystonia). Long-term use may induce tolerance, with potential withdrawal symptoms upon abrupt discontinuation.
   • Contraindications: Hypersensitivity to Rotundine; caution in pregnancy, lactation, and severe hepatic/renal dysfunction. Avoid driving or operating machinery during treatment.

II. Applications

1. Clinical Uses
   • Pain Management:
     • Visceral Pain: Relieves gastric/duodenal ulcers, biliary spasms, and other visceral pain.
     • Headache and Dysmenorrhea: Treats mild-to-moderate headaches and menstrual pain.
     • Postpartum Uterine Pain: Alleviates postpartum uterine contractions.
     • Postoperative/Traumatic Pain: Provides mild relief for postoperative and minor traumatic pain but is ineffective for severe postoperative or advanced cancer pain.
   • Sleep Disorders: Improves insomnia, especially pain-related sleep disturbances, typically administered 30–90 mg pre-sleep.
   • Other Indications: Used for antitussive, antiarrhythmic, hypotensive, and functional dyspepsia therapies.
   • 
     
2. Pharmaceutical Formulations
   • Oral Preparations: Rotundine Tablets (60–120 mg/dose, 1–4 times daily; adjusted per condition). For sleep aid: 30–90 mg/dose, three times daily, with pre-sleep administration.
   • Injectables: Administered by healthcare professionals; dosage (per physician’s orders).
3. 
   
4. Drug Interactions
   • CNS depressants (e.g., alcohol, hypnotics) may potentiate sedation; avoid concurrent use.
   • Dosage adjustments may be required with hepatic enzyme inhibitors/inducers (e.g., rifampicin).